WamaiR, MorrisBJ. ‘How to contain generalized HIV epidemics’ article misconstrues the evidence. Int J STD AIDS2011;22:415–16
2.
GisselquistD, PotteratJJ, St. LawrenceJS, How to contain generalized HIV epidemics? A plea for better evidence to displace speculation. Int J STD AIDS2009;20:443–6
3.
AuvertB, TaljaardD, LagardeE, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med2005;2:e298
4.
GrayRH, KigoziG, SerwaddaD, Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet2007;369:657–66
5.
BaileyRC, MosesS, ParkerCB, Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet2007;369:643–56
6.
WilliamsBG, Lloyd-SmithJO, GouwsE, The potential impact of male circumcision on HIV in sub-Saharan Africa. PLoS Med2006;3:e262
7.
KumwendaJJ, MakananiB, TauloF, Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi. Clin Inf Dis2008;46:1913–20
8.
GisselquistD. Points to Consider: Responses to HIV/AIDS in Africa, Asia, and the Caribbean. London: Adonis & Abbey, 2008. See http://sites.google.com/site/davidgisselquist/pointstoconsider (last accessed 13 May 2011)
9.
PetersEJ, BrewerDD, UdonwaNE, Diverse blood exposures associated with incident HIV infection in Calabar, Nigeria. Int J STD AIDS2009;20:846–51
10.
OkinyiM, BrewerDD, PotteratJJ. Horizontally-acquired HIV infection in Kenyan and Swazi children. Int J STD AIDS2009;20:852–7
11.
St LawrenceJS, KlaskalaW, KankasaC, WestJT, MitchelCD, WoodC. Factors associated with HIV prevalence in a pre-partum cohort of Zambian women. Int J STD AIDS2006;17:607–13
12.
BuchbinderSP, MehrotraDV, DuerrA, Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet2008;372:1881–93
